After winning approval in the United States back in September, Sanofi Genzyme’s multiple sclerosis drug, aubagio, has won approval for use in Australia. The Australian Therapeutic Goods ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Neurizon Therapeutics Limited, a clinical-stage biotech company dedicated to advancing innovative treatments for ...

In the United States, Genzyme beat TKT and garnered exclusive US approval with the seven-year Orphan Drug exclusivity due to a superior clinical development programme. Experts believe that 4,000 ...

The FDA has cleared their once-weekly Factor VIII ... of the week,” according to Bill Sibold – head of the Sanofi Genzyme unit, which will be responsible for marketing the new drug – who ...

H1N1 Flu Wave Peaking in US? New cases of the H1N1 flu have declined, but deaths and hospitalizations are still rising. WebMD Health News, November 20, 2009 Med Schools and Ghostwriting As part of ...

He covers federal public health agencies. The Food and Drug Administration is drawing up plans that would end most of its routine food safety inspections work, multiple federal health officials ...

The Food and Drug Administration (FDA) is coming under fire for not publicizing its own report into an E. coli outbreak last year that spread across 15 states and infected 89 people, one of whom died.

The FDA has suspended its food testing lab quality control program due to staffing cuts. Staffing cuts at HHS agencies, including the FDA, have occurred since Robert F. Kennedy Jr.'s confirmation ...

The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster drug Dupixent for patients with ...